SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009013
Filing Date
2024-06-07
Accepted
2024-06-07 16:30:24
Documents
14
Period of Report
2024-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20240606x8k.htm   iXBRL 8-K 64123
  Complete submission text file 0001558370-24-009013.txt   185743

Data Files

Seq Description Document Type Size
2 EX-101.SCH gbio-20240606.xsd EX-101.SCH 3940
3 EX-101.DEF gbio-20240606_def.xml EX-101.DEF 2734
4 EX-101.LAB gbio-20240606_lab.xml EX-101.LAB 13958
5 EX-101.PRE gbio-20240606_pre.xml EX-101.PRE 10832
17 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20240606x8k_htm.xml XML 4614
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 241030030
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)